Bioavailability and Food Effect Study of Two Formulations of PF-06650833
NCT03308110 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2019-04-19
Summary
Bioavailability and food effect of 2 formulations of PF-06650833 in healthy volunteers.
Conditions
- Healthy
Interventions
- DRUG
-
PF-06650833
Two formulations of PF-006650833
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Study Design
- Purpose
- OTHER
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-09-08
- Primary Completion
- 2017-12-08
- Completion
- 2018-01-11
Countries
- Belgium
Study Locations
More Related Trials
-
OPEN LABEL, 2-PERIOD STUDY, TO COMPARE BIO-AVAILABILITY OF 2 DIFFERENT FORMULATIONS OF PF-05221304 IN HEALTHY ADULTS
NCT03871439 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability Study Of PF-06651600 In Healthy Subjects
NCT02684760 ·Status: COMPLETED ·Phase: PHASE1
-
The Bioavailability of a Spray Dried Dispersion Solid Dose Formulation of PF-06260414 Relative to a Suspension Formulation
NCT02393807 ·Status: WITHDRAWN ·Phase: PHASE1
-
Study to Evaluate Pharmacokinetics of A Modified Release Formulation of PF-06650833 in Healthy Subjects
NCT02609139 ·Status: COMPLETED ·Phase: PHASE1
-
Food Effect Study for PF-06372865
NCT02217787 ·Status: COMPLETED ·Phase: PHASE1
-
AStudy to Evaluate the Bioavailability of PF 04965842 in Healthy Subjects
NCT02163161 ·Status: COMPLETED ·Phase: PHASE1
-
Food Effect Study PF-04136309
NCT02598206 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Of PF-03882845 Absorption In Healthy Volunteers Given Orally As Tablet Versus Suspension Formulations And Effect Of Food On Its Absorption
NCT01366287 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Relative Bioavailability of a Modified-Release Formulation of PF-05180999
NCT01530529 ·Status: COMPLETED ·Phase: PHASE1
-
PHARMACOKINETIC CHARACTERIZATION OF PF-06651600 IN CHINESE ADULT PARTICIPANTS
NCT04634565 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of PF-06852231 in Healthy Subjects
NCT03217604 ·Status: COMPLETED ·Phase: PHASE1
-
A Healthy Volunteer Study To Assess Relative Bioavailability Of Powder-In-Capsule And A Tablet Formulation And The Effect Of Food On The Pharmacokinetics Of The Tablet Formulation
NCT01821079 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn PF-07817883 Blood Levels After Administration of Tablets of Study Drug to Healthy Adult Volunteers
NCT06122194 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects
NCT01626976 ·Status: COMPLETED ·Phase: PHASE1
-
Study for MR Formulation of PF-06650833 in Healthy Adult Japanese Subjects
NCT02936154 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Effect of Tablet Formulation and Food on PF-07104091 in Healthy Participants
NCT05431153 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06372865 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)
NCT02070289 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Assess The Safety, Tolerability, And Pharmacokinetics (PK) Of Multiple Doses Of PF-06865571 In Healthy, Including Overweight And Obese, Adult Subjects
NCT03230383 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Comparing PF-06273340 Immediate Release Tablet, PF-06273340 Modified Release Tablets To PF-06273340 Oral Solution In The Fasted State. This Study Will Also Compare PF-06273340 Modified Release Tablets In Fasted And Fed State
NCT01706796 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study To Evaluate The Safety And Tolerability Of PF-06252616 In Healthy Subjects
NCT01616277 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Safety and Tolerability of Single Ascending Doses of Multiple Formulations of PF-06650833 in Healthy Subjects Under Fasted and Fed Conditions
NCT02224651 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of PF-06651600 in Subjects With Hepatic Impairment and Healthy Volunteers
NCT04016077 ·Status: COMPLETED ·Phase: PHASE1
-
A Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics And Pharmacodynamics Of Multiple Oral Doses Of PF-06743649
NCT02151617 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Repeat Doses of PF-06372865 in Healthy Subjects
NCT03351751 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate Different Formulations of S-337395 in Healthy Adult Participants
NCT06270511 ·Status: COMPLETED ·Phase: PHASE1